It is shown that APOE4 networks retain a capacity for adaptive plasticity enabling restoration of local neuronal function, but that this recovery does not extend to higher-order network organization.
Abstract
The apolipoprotein E ε4 (APOE4) allele is the strongest genetic risk factor for developing sporadic Alzheimer’s disease (AD), which accounts for the vast majority of AD cases. Ion dysfunction has emerged as a central mechanism involved in APOE4-related pathology, reflecting the importance of ion homeostasis for cell membrane excitability, synaptic transmission, and plasticity. We have previously demonstrated that ion dysfunction contributes to early AD-related network vulnerability, and that engaging synaptic plasticity mechanisms via ion modulation can restore network balance in neurodegenerative disease. Here, we investigated whether synaptic mobilization by ion modulation could ameliorate APOE4-associated dysfunction in human neuronal networks compared with isogenic APOE3 controls. APOE4 networks exhibited progressive structural and functional deterioration, manifesting as increased neurite length, reduced neurite branching, and reduced firing rate and number of active recording electrodes. This was accompanied by compensatory hypersynchronization, rendering networks vulnerable to pathological spread, and reduced synaptic AMPAR levels compared with isogenic APOE3 control networks. Modulating ion homeostasis restored the local firing dynamics and stabilized synaptic AMPAR levels. However, the elevated synchronization and aberrant morphology of APOE4 networks were not alleviated by engaging synaptic plasticity mechanisms, demonstrating that APOE4 networks retain a capacity for adaptive plasticity enabling restoration of local neuronal function, but that this recovery does not extend to higher-order network organization.
Pathological tau disrupts neuronal activity and brain function in Alzheimer’s disease and other tauopathies. However, the underlying mechanisms for neuronal network dysfunction remain largely unknown. Using human inducible pluripotent stem cell (iPSC) - derived neurons, we show that the familial MAPT P301L mutation lea...
Chang-Yi Ji, Yunlu Zhu, Hediye Erdjument-Bromage et al.· bioRxiv· 0 citations
Memory storage and recall are essential tasks for the healthy function of the hippocampus, adversely affected by neurodegenerative diseases, such as Alzheimer’s Disease (AD). Pathological levels of amyloid-β peptide (Aβ), found already in early-stage AD, can disrupt the NMDAR-dependent plasticity at hippocampal network...
Fabio Librizzi, Saana Seppälä, M. Linne et al.· Frontiers in Computational N...· 0 citations
It is demonstrated that, during AD progression in mice, astrocytes and microglia increase phagocytic elimination of excitatory synapses while reducing elimination of inhibitory synapses, suggesting that neuroinflammation alone may be dispensable for early AD synapse loss.
Seyoung Lee, Eunseok Park, Ha-Eun Lee et al.· Nature· 2 citations· ⚡1
Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD) share progressive memory impairment, yet their upstream pathologies differ. This review synthesizes evidence across these disorders to frame memory decline through engram ensembles and proposes an excita...
Qing-Yu Bai, Yan Yan, Chao-Wen Zeng et al.· Frontiers in Aging Neuroscie...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.